Type 2 Diabetes Market by Leading Players are Eli Lilly and Co., Sanofi Aventis A/S, Novo Nordisk, Merck & Co., Inc., Chugai Pharmaceutical Co., Bristol-Myers Squibb, Pfizer Inc., Bayer AG, GlaxoSmithKline Plc., and AstraZeneca Plc.

Type 2 diabetes (T2D) is a chronic disease that affects bodys blood sugar level. Elevated blood sugar level (hyperglycemia) causes detrimental effects on heart, kidneys, eyes, blood vessels, and nerves.

The major factor that drive the growth of the global type 2 diabetes (T2D) market are increase in prevalence of T2D disease globally. As per NCBI, 89 million cases of T2DM were recorded in 2014, and its prevalence is expected to reach to 330 million cases by 2022. Moreover, advancements in diabetic medications by pharmaceutical manufacturers fuel the market growth.

Get sample PDF copy @ https://www.alliedmarketresearch.com/request-toc-and-sample/3964

Jardiance, a sodiumglucose cotransporter 2 inhibitor, and Tanzeum & Trulicity, two glucagon-like peptide-1 receptor agonists are the newest medications introduced in the market. However, lack of awareness among patients towards the availability of such medications restrains the market growth. Conversely, unmet medical needs in emerging economies are expected to provide lucrative growth opportunities for the market.

The report segments the global type 2 diabetes market based on drug class, application, and geography. On the basis of drug class, the market is categorized into dipeptidyl peptidase-4 (DPP-4) inhibitors, glucagon-like peptide-1 (GLP-1) receptor agonists, thiazolidinediones, alpha-glucosidase inhibitors, sulfonylureas & other insulin secretagogues, biguanides, and sodiumglucose cotransporter 2 inhibitors. In terms of application, it is divided into glycemic control, cardiovascular safety, hypoglycemia avoidance, and others. Regionally, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key players operating in the market include Eli Lilly and Co., Sanofi Aventis A/S, Novo Nordisk, Merck & Co., Inc., Chugai Pharmaceutical Co., Bristol-Myers Squibb, Pfizer Inc., Bayer AG, GlaxoSmithKline Plc., and AstraZeneca Plc.

Key Benefits

This report provides an extensive analysis of the current & emerging market trends and dynamics in the global type 2 diabetes market.

Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities across the geographies.

This report entails the detailed quantitative analysis of the current market and estimations from 2016 to 2023 to identify the prevailing opportunities.

Comprehensive analysis of factors that drive and restrict the market growth is provided in the report.

Region- and country-wise market conditions are comprehensively analyzed in the report.

Type 2 Diabetes Market Key Segments:

By Drug Class

Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists
Thiazolidinediones
Alpha-glucosidase Inhibitors
Sulfonylureas & Other Insulin Secretagogues
Biguanides
SodiumGlucose Cotransporter 2 Inhibitors

Do purchase inquiry @ https://www.alliedmarketresearch.com/purchase-enquiry/3964

By Application

Glycemic Control
Cardiovascular Safety
Hypoglycemia Avoidance
Others

About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:
Shriram Dighe
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

This release was published on openPR.